LUISI, STEFANO
 Distribuzione geografica
Continente #
AS - Asia 2.933
NA - Nord America 2.368
EU - Europa 489
SA - Sud America 290
AF - Africa 41
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.122
Nazione #
US - Stati Uniti d'America 2.311
CN - Cina 1.024
SG - Singapore 862
HK - Hong Kong 388
BR - Brasile 231
KR - Corea 205
VN - Vietnam 196
IT - Italia 108
JP - Giappone 86
FR - Francia 80
RU - Federazione Russa 47
FI - Finlandia 45
SE - Svezia 43
GB - Regno Unito 41
IN - India 39
DE - Germania 35
CA - Canada 27
TR - Turchia 24
BG - Bulgaria 22
IQ - Iraq 20
UA - Ucraina 20
AR - Argentina 19
BD - Bangladesh 17
MX - Messico 14
EC - Ecuador 13
ZA - Sudafrica 13
ID - Indonesia 10
NL - Olanda 10
PL - Polonia 9
PK - Pakistan 8
CO - Colombia 7
CH - Svizzera 6
ES - Italia 6
KE - Kenya 6
PH - Filippine 6
UZ - Uzbekistan 6
EG - Egitto 5
PE - Perù 5
TH - Thailandia 5
UY - Uruguay 5
CR - Costa Rica 4
DO - Repubblica Dominicana 4
MA - Marocco 4
NG - Nigeria 4
SA - Arabia Saudita 4
AE - Emirati Arabi Uniti 3
AT - Austria 3
AZ - Azerbaigian 3
JO - Giordania 3
LT - Lituania 3
PY - Paraguay 3
AL - Albania 2
AM - Armenia 2
BH - Bahrain 2
CI - Costa d'Avorio 2
CL - Cile 2
EE - Estonia 2
ET - Etiopia 2
GA - Gabon 2
GY - Guiana 2
IE - Irlanda 2
IR - Iran 2
JM - Giamaica 2
KZ - Kazakistan 2
LB - Libano 2
MY - Malesia 2
NP - Nepal 2
OM - Oman 2
PA - Panama 2
RS - Serbia 2
TW - Taiwan 2
VE - Venezuela 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BE - Belgio 1
BJ - Benin 1
BO - Bolivia 1
CW - ???statistics.table.value.countryCode.CW??? 1
GE - Georgia 1
GR - Grecia 1
IL - Israele 1
KG - Kirghizistan 1
MN - Mongolia 1
NI - Nicaragua 1
PS - Palestinian Territory 1
SN - Senegal 1
SV - El Salvador 1
TJ - Tagikistan 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 6.122
Città #
Singapore 514
Hong Kong 383
Santa Clara 350
Hefei 333
Ashburn 330
San Jose 247
Shanghai 241
Seoul 205
Dallas 202
Boardman 184
Woodbridge 112
Tokyo 85
Fairfield 80
Beijing 77
Ho Chi Minh City 67
Los Angeles 66
Chandler 51
Houston 45
Lauterbourg 39
Hanoi 37
Wilmington 33
Helsinki 32
Seattle 30
Ann Arbor 27
Cambridge 25
New York 25
Buffalo 23
Sofia 22
Council Bluffs 21
Milan 20
São Paulo 18
Redondo Beach 17
Jacksonville 15
Da Nang 13
Munich 13
Haiphong 12
Hyderabad 11
Baltimore 10
Dearborn 10
Istanbul 10
Princeton 10
Ogden 9
Ottawa 9
Boulder 8
Frankfurt am Main 8
Lawrence 8
Medford 8
Warsaw 8
Belo Horizonte 7
Cascina 7
Chicago 7
Izmir 7
Nanjing 7
Pisa 7
Turku 7
Baghdad 6
Cape Town 6
Florence 6
Fuzhou 6
Nairobi 6
Orem 6
Salvador 6
San Francisco 6
Tashkent 6
Atlanta 5
Biên Hòa 5
Chennai 5
Guayaquil 5
Indianapolis 5
Lancaster 5
London 5
Medellín 5
Nanchang 5
Quanzhou 5
Roubaix 5
Shenyang 5
The Dalles 5
Toronto 5
Brasília 4
Columbus 4
Curitiba 4
Des Moines 4
Erbil 4
Falkenstein 4
Falls Church 4
Guangzhou 4
Hải Dương 4
Jakarta 4
Johannesburg 4
Lagos 4
Manchester 4
Mexico City 4
Mumbai 4
Porto Alegre 4
Quito 4
Rio de Janeiro 4
Rome 4
San José 4
Vũng Tàu 4
Wuhan 4
Totale 4.364
Nome #
Factors in malignant transformation of ovarian endometriosis: A narrative review 191
Brain-derived neurotrophic factor in plasma of women with endometriosis 179
Brain-derived neurotrophic factor plasma variation during the different phases of the menstrual cycle in women with premenstrual syndrome 175
Changes of Activin A Secretion in Gestational Diseases 168
Paracrine regulation of human placenta: control of hormonogenesis 162
Gestosi ed ormoni placentari: nuove acquisizioni 142
Paroxetine increases brain-derived neurotrophic factor in postmenopausal women 142
Vascular endothelial growth factor and interleukin-8 in ovarian cystic pathology 140
Functional polymorphism within NUP210 encoding for nucleoporin GP210 is associated with the risk of endometriosis 128
PCOS Physiopathology and Vitamin D Deficiency: Biological Insights and Perspectives for Treatment 118
Sexually dimorphic effects of testosterone administration on brain allopregnanolone in gonadectomized rats 114
Transvaginal sonographic features of diffuse adenomyosis in 18-30-year-old nulligravid women without endometriosis: association with symptoms 110
Genitopelvic pain: Retrospective evaluation of a multimodal treatment efficacy 108
Role of lateral suspension for the treatment of pelvic organ prolapse: a Delphi survey of expert panel 107
Endometriosis: seeking optimal management in women approaching menopause 102
Extracellular matrix remodeling and inflammatory pathway in human endometrium: insights from uterine leiomyomas 102
Neonatal outcome in pregnancy hypotiroidee women 102
Expression of matrix metalloproteinases and their inhibitors in endometrium: High levels in endometriotic lesions 102
Role of medical treatment of endometriosis 97
Dermoscopic and reflectance confocal microscopy features of two cases of vulvar basal cell carcinoma 96
Autophagy up-regulation by ulipristal acetate as a novel target mechanism in the treatment of uterine leiomyoma: an in vitro study 94
Adenomyosis: What the Patient Needs 93
Sexual pain in women: Quality of sex life and marital relations 91
Increased expression of neurogenic factors in uterine fibroids 91
Hormonal therapy for endometriosis: from molecular research to bedside 90
Abnormal uterine bleeding unrelated to structural uterine abnormalities: management in the perimenopausal period 89
Overweight and lower age at menarche: Evidence from the Italian HBSC cross-sectional survey 89
Naproxen sodium decreases prostaglandins secretion from cultured human endometrial stromal cells modulating metabolizing enzymes mRNA expression 87
Diagnosis and management of symptoms associated with vulvovaginal atrophy: expert opinion on behalf of the Italian VVA study group 81
Surgical treatment affects perceived stress differently in women with endometriosis: Correlation with severity of pain 81
Dienogest. A possible conservative approach in bladder endometriosis. Results of a pilot study 80
Autophagy is upregulated in ovarian endometriosis: A possible interplay with p53 and heme oxygenase-1 79
Modern operative hysteroscopy 78
Ovarian Endometrioma: What the Patient Needs 77
Expression, localization and control of activin A release from human umbilical vein endothelial cells 77
Ogilvie's Syndrome in an obstetric patients 74
Serum markers for the noninvasive diagnosis of endometriosis 74
How to manage bowel endometriosis: The ETIC approach 72
Different Expression of Hypoxic and Angiogenic Factors in Human Endometriotic Lesions 72
When more is not better: 10 'don'ts' in endometriosis management. An ETIC* position statement 69
Parenterally Administered Moderate Sedation and Paracervical Block Versus General Anesthesia for Hysteroscopic Polypectomy: A Pilot Study Comparing Postoperative Outcomes 67
Regulation of autophagy in the uterus: from physiological processes to endometriosis and uterine fibroids 67
Genes involved in the pathogenesis of premature ovarian insufficiency 64
Neuroendocrine and stress-related aspects of endometriosis 63
Office hysteroscopy: an update 61
Attitudes and perceptions towards vulvar and vaginal atrophy in Italian post-menopausal women: Evidence from the European REVIVE survey 55
Mood disorders and quality of life in polycystic ovary syndrome 52
The addition of activin A and inhibin A measurement to uterine artery Doppler velocimetry to improve the early prediction of pre-eclampsia 47
Premature ovarian insufficiency: From pathogenesis to clinical management 41
Single serum activin a testing to predict ectopic pregnancy 40
Neuroendocrine aspects of placenta and pregnancy 29
Hormone-dependent gynaecological disorders: a pathophysiological perspective for appropriate treatment 27
Vaginally administered estroprogestinic decreases serum inhibin A and inhibin B levels and reduces endometrial thickness 25
Circulating Levels of Allopregnanolone, a Neuroactive Steroid, and Leptin during Treatment with Valproic Acid in Children with Epilepsy 23
Corticotropin-releasing factor, urocortin and endothelin-1 stimulate activin A release from cultured human placental cells 23
Role of placental inhibin and activin 23
Inhibin B is the major form of inhibin/activin family secreted by granulosa cell tumors 23
Increased serum inhibin B levels in postmenopausal women with altered thyroid function 23
Maternal position during non-stress test and fetal heart rate patterns 23
Efficacy of vaginal danazol treatment in women with recurrent deeply infiltrating endometriosis 23
Reduced pelvic pain in women with endometriosis: efficacy of long-term dienogest treatment 23
Activin a Stimulates Interleukin 8 and Vascular Endothelial Growth Factor Release From Cultured Human Endometrial Stromal Cells: Possible Implications for the Pathogenesis of Endometriosis 23
Activin A and follistatin in menstrual blood: low concentrations in women with dysfunctional uterine bleeding 22
Inhibins and activins in pregnancy 22
Increased plasma concentrations of activin a predict intraventricular hemorrhage in preterm newborns 22
Umbilical cord blood inhibin A and activin A levels in healthy and pathological conditions 22
Effects of the new generation selective estrogen receptor modulator EM-652 and oral administration of estradiol valerate on circulating, brain, and adrenal beta-endorphin and allopregnanolone levels in intact fertile and ovariectomized rats 22
Estrogen receptor gene polymorphisms are associated with recurrence of endometriosis 21
Relaxin in endometriosis 21
Allopregnanolone levels decrease after gonadotropin-releasing hormone analog stimulation test in girls with central precocious puberty 21
Placental hormones and coagulation factors to define women at risk of developing preeclampsia 21
Inhibin A, inhibin B and activin A concentrations in umbilical cord artery and vein 21
Patients with functional hypothalamic amenorrhea are characterized by low serum inhibin B concentrations 21
Activin A in brain injury 21
Maternal dietary habits and mycotoxin occurrence in human mature milk 20
Neuroendocrinology of human placenta 20
Yolk sac tumor in a young girl: a case report 20
Umbilical cord serum activin A levels are increased in pre-eclampsia with impaired blood flow in the uteroplacental and fetal circulation 19
Abnormal umbilical artery Doppler waveforms and cord blood inhibin a and inhibin B levels 19
Maternal serum inhibin A measurement may predict the pregnancy outcome in women with threatened abortion 19
Evaluation of circulating activin-A as a serum marker of hepatocellular carcinoma 19
Endometriosis in Italy: From cost estimates to new medical treatment 19
Influence of non-gonadotrophic hormones on gonadal function 19
High serum allopregnanolone levels in girls with precocious puberty 19
Use of a progestogen only preparation containing desogestrel in the treatment of recurrent pelvic pain after conservative surgery for endometriosis 19
Serum anti-Müllerian hormone, inhibin B, and total inhibin levels in women with hypothalamic amenorrhea and anorexia nervosa 19
Serum activin A levels are lower in tubal than intrauterine spontaneously conceived pregnancies 19
Vaginally administered estroprogestinic decreases serum inhibin A and inhibin B levels and reduces endometrial thickness 19
Hormone-dependent gynaecological disorders: a pathophysiological perspective for appropriate treatment 19
Corticotropin-releasing factor (CRF) e peptidi ad esso correlati nei meccanismi di scatenamento del parto 18
Hormone replacement therapy in menopause and in premature ovarian insufficiency 18
Inhibins in female and male reproductive physiology: role in gametogenesis, conception, implantation and early pregnancy 17
Endometrial expression and secretion of activin A, but not follistatin, increase in the secretory phase of the menstrual cycle 17
Preeclampsia with fetal growth restriction: placental and serum activin A and inhibin A levels 17
Chronic pelvic pain and quality of life in women with and without endometriosis 17
Efficacy of vaginal danazol treatment in women with menorrhagia during fertile age 17
Efficacy of vaginal danazol treatment in women with recurrent deeply infiltrating endometriosis 17
Local drug release systems in endometriosis 16
Low serum and peritoneal fluid concentration of interferon-gamma-induced protein-10 (CXCL 10) in women with endometriosis 16
Serum inhibin A, inhibin B, and pro-alphaC levels are altered after surgically or pharmacologically induced menopause 16
Totale 5.799
Categoria #
all - tutte 20.304
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.304


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202118 0 0 0 0 0 0 0 0 0 0 7 11
2021/2022102 6 6 3 6 17 17 2 3 6 7 4 25
2022/2023116 11 12 9 13 16 16 0 14 20 0 4 1
2023/2024419 8 11 14 6 8 22 1 178 77 11 26 57
2024/20252.574 3 131 190 66 238 295 124 60 170 311 400 586
2025/20262.642 210 498 335 158 202 180 363 130 208 236 122 0
Totale 6.387